GV 2016, L.P.'s Net Worth

$280 Million

Who is GV 2016, L.P.?

GV 2016, L.P. has an estimated net worth of $280 Million. This is based on reported shares across multiple companies, which include IonQ, Inc., Magenta Therapeutics, Inc., Arcus Biosciences, Inc., ARMO BioSciences, Inc., Arsanis, Inc., Decibel Therapeutics, Inc., and Starco Brands, Inc..

SEC CIK

GV 2016, L.P.'s CIK is 0001721789

Past Insider Trading and Trends

2018 was GV 2016, L.P.'s most active year for acquiring shares with 3 total transactions. GV 2016, L.P.'s most active month to acquire stocks was the month of December. 2018 was GV 2016, L.P.'s most active year for disposing of shares, totalling 4 transactions. GV 2016, L.P.'s most active month to dispose stocks was the month of March. 2018 saw GV 2016, L.P. paying a total of $0.00 for 7,071,799 shares, this is the most they've acquired in one year. In 2022 GV 2016, L.P. cashed out on 3,186,822 shares for a total of $6,074,458.20, their largest year based on trade value.